Primary structure, recombinant expression and homology modelling of human brain prolyl oligopeptidase, an important therapeutic target in the treatment of neuropsychiatric diseases

Journal of Peptide Science

Volumn 11, Issue 5, 2005, Pages 283-287

  Tarragó, Teresa ^a   Sabidoó, Eduard ^a   Kogan, Marcelo Javier ^b   De Oliveira, Eliandre ^c   Giralt, Ernest ^a,c  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar affective disorder; Neuropeptides; Prolyl oligopeptidase; Proteomics; Schizophrenia; Structural homology model

Indexed keywords

PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; S 17092 1; SUAM 14746; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; CONFORMATIONAL TRANSITION; DRUG MECHANISM; DRUG TARGETING; HUMAN; MENTAL DISEASE; MOLECULAR CLONING; NEUROPSYCHIATRY; NUCLEOTIDE SEQUENCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

EID: 18844395154     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.676     Document Type: Article

References (28)

1. Palumbo M, Rodin RL, Goodman M. Synthesis and conformational studies in solution of sequential copolypeptides. Poly(L-prolyl-L-α-phenylgiycyl-L-proline). Biochemistry 1975; 14: 485-491.
2. Goodman M, Niu GCC, Su K. Conformational aspects of polypeptide structure. XXXI. Helical poly[(S)-thiazolidine-4-carboxylic acid] and poly[(S)-oxazolidine-4-carboxylic acid]. Theoretical results. J. Am. Chem. Soc. 1970; 92: 5219-5220.
3. Goodman M, Bhumralkar M, Jefferson EA, Kwak J, Locardi E. Collagen mimetics. Biopolymers (Pept. Sci.) 1998; 47: 127-142.
4. Kinberger GA, Cai W, Goodman M. Collagen mimetic dendrimers. J. Am. Chem. Soc. 2002; 124: 15 162-15 163.
5. Crespo L, Sanclimens G, Montaner B, Perez-Tomas R, Royo M, Pons M, Albericio F, Giralt E. Peptide dendrimers based on polyproline helices. J. Am. Chem. Soc. 2002; 124: 8876-8883.
6. Farrera-Sinfreu J, Zaccaro L, Vidal D, Salvatella X, Giralt E, Pons M, Albericio F, Royo M. A new class of foldamers based on cis-amino-L-proline. J. Am. Chem. Soc. 2004; 126: 6048-6057.
7. Polgar L. The prolyl oligopeptidase family. Cell. Mol. Life Sci. 2002; 59: 349-362.
8. Polgar L. Structure-function of prolyl oligopeptidase and its role in neurological disorders. Curr. Med. Chem.-Central Nervous System Agents 2002; 2: 251-257.
9. Maes M, Goossens F, Scharpe S, Calabrese J, Desnyder R, Meltzer HY. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res. 1995; 58: 217-225.
10. Maes M, Goossens F, Lin A, De Meester I, Van Gastel A, Scharpe S. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Psychoneuroendocrinology 1998; 23: 485-495.
11. Maes M, Lin AH, Bonaccorso S, Goossens F, Van Gastel A, Pioli R, Delmeire L, Scharpe S. Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder. J Affect Disord. 1999; 53: 27-34.
12. Fulop V, Bocskei Z, Polgar L. Prolyl oligopeptidase: an unusual Β-propeller domain regulates proteolysis. Cell 1998; 94: 161-170.
13. Vanhoof G, Goossens F, Hendriks L, De Meester I, Hendriks D, Vriend G, Van Broeckhoven C, Scharpe S. Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase. Gene 1994; 149: 363-366.
14. Shirasawa Y, Osawa T, Hirashima A. Molecular cloning and characterization of prolyl endopeptidase from human T cells. J. BioChem. (Tokyo) 1994; 115: 724-729.
15. Wong AH, Van Tol HH. Schizophrenia: from phenomenology to neurobiology. Neurosci. Biobehav. Rev. 2003; 27: 269-306.
16. Bellemere G, Morain P, Vaudry H, Jegou S. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and α-melanocyte-stimulating hormone breakdown in the rat brain. J. Neurochem. 2003; 84: 919-929.
17. Song KS, Raskin I. A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex. J. Nat. Prod. 2002; 65: 76-78.
18. Kobayashi W, Miyase T, Sano M, Umehara K, Warashina T, Noguchi H. Prolyl endopeptidase inhibitors from the roots of Lindera strychnifolia F. Vill. Biol. Pharm. Bull. 2002; 25: 1049-1052.
19. Szeltner Z, Renner V, Polgar L. Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein Sci. 2000; 9: 353-360.
20. Venalainen JI, Juvonen RO, Forsberg MM, Garcia-Horsman A, Poso A, Wallen EA, Gynther J, Mannisto PT. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819. Biochem. Pharmacol. 2002; 64: 463-471.
21. Szeltner Z, Rea D, Renner V, Juliano L, Fulop V, Polgar L. Electrostatic environment at the active site of prolyl oligopeptidase is highly influential during substrate binding. J. Biol. Chem. 2003; 278: 48 786-48 793.
22. Wallen EA, Christiaans JA, Jarho EM, Forsberg MM, Venalainen JI, Mannisto PT, Gynther J. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(1-prolyl-pyrrolidine) amides. J. Med. Chem. 2003; 46: 4543-4551.
23. Vendevine S, Goossens F, Debreu-Fontaine MA, Landry V, Davioud-Charvet E, Grellier P, Scharpe S, Sergheraert C. Comparison of the inhibition of human and Trypanosoma cruzi prolyl endopeptidases. Bioorg. Med. Chem. 2002; 10: 1719-1729.
24. Miura N, Shibata S, Watanabe S. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. Neurosci. Lett. 1995; 196: 128-130.
25. Bareni H, Petit A, Hirsch E, Wilk S, De Nanteuil G, Morain P, Checler F. S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Biochem. Biophys. Res. Commun. 1999; 257: 657-661.
26. Saito M, Hashimoto M, Kawaguchi N, Fukami H, Tanaka T, Higuchi N. Synthesis and inhibitory activity of acyl-peptidyl-prolinal derivatives toward post-proline cleaving enzyme as nootropic agents. J. Enzyme Inhib. 1990; 3: 163-178.
27. Augustynsa K, Borlooa M, Belyaeva A, Rajana P, Goossens F, Hendriks D, Scharpé S, Haemers A. Synthesis of peptidyl acetals as inhibitors of prolyl endopeptidase. Bioorg. Med. Chem. Lett. 1995; 5: 1265-1270.
28. DeWeese-Scott C, Moult J. Molecular modeling of protein function regions. Proteins 2004; 55: 942-961.